ArticleSignal transduction and targeted therapy2023

CRISPRing the hypertrophic cardiomyopathy: correcting one pathogenic variant at a time.

Junaid Afzal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.